Clinical Trial Update: Study of Combination of Ipilimumab and Nivolumab in Patients With Melanoma [Phase 2]

View source ↗

Summary

This Phase 2 study evaluated the combination of ipilimumab and nivolumab in patients with melanoma. The trial has completed and results were posted on 2020-03-1…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: NYU Langone Health | Conditions: Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2020-03-11